Summit Therapeutics Inc (NASDAQ: SMMT) is 8.10% higher on its value in year-to-date trading and has touched a low of $2.10 and a high of $33.89 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SMMT stock was last observed hovering at around $20.32 in the last trading session, with the day’s loss setting it -1.03%.
Currently trading at $19.29, the stock is -1.60% and -5.77% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.45 million and changing -5.07% at the moment leaves the stock 12.31% off its SMA200. SMMT registered 414.40% gain for a year compared to 6-month loss of -15.43%. The firm has a 50-day simple moving average (SMA 50) of $20.4716 and a 200-day simple moving average (SMA200) of $17.17535.
The stock witnessed a -6.77% gain in the last 1 month and extending the period to 3 months gives it a 0.05%, and is -6.77% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.29% over the week and 6.98% over the month.
Summit Therapeutics Inc (SMMT) has around 159 employees, a market worth around $14.23B and $0.00M in sales. Distance from 52-week low is 818.57% and -43.08% from its 52-week high. The company has generated returns on investments over the last 12 months (-56.43%).
The EPS is expected to shrink by -38.33% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Summit Therapeutics Inc (SMMT) Top Institutional Holders
273.0 institutions hold shares in Summit Therapeutics Inc (SMMT), with institutional investors hold 82.62% of the company’s shares. The shares outstanding are 737.63M, and float is at 115.12M with Short Float at 18.43%. Institutions hold 12.92% of the Float.
The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 23.22 million shares valued at $181.13 million. The investor’s holdings represent 3.2804% of the SMMT Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 8.82 million shares valued at $68.78 million to account for 1.2566 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 7.9 million shares representing 1.1158% and valued at over $61.61 million, while FMR LLC holds 1.0687 of the shares totaling 7.57 million with a market value of $59.01 million.
Summit Therapeutics Inc (SMMT) Insider Activity
#####
